Literature DB >> 33672582

Extracellular Protein Aggregates Colocalization and Neuronal Dystrophy in Comorbid Alzheimer's and Creutzfeldt-Jakob Disease: A Micromorphological Pilot Study on 20 Brains.

Nikol Jankovska1, Tomas Olejar1, Radoslav Matej1,2,3.   

Abstract

Alzheimer's disease (AD) and sporadic Creutzfeldt-Jakob disease (sCJD) are both characterized by extracellular pathologically conformed aggregates of amyloid proteins-amyloid β-protein (Aβ) and prion protein (PrPSc), respectively. To investigate the potential morphological colocalization of Aβ and PrPSc aggregates, we examined the hippocampal regions (archicortex and neocortex) of 20 subjects with confirmed comorbid AD and sCJD using neurohistopathological analyses, immunohistochemical methods, and confocal fluorescent microscopy. Our data showed that extracellular Aβ and PrPSc aggregates tended to be, in most cases, located separately, and "compound" plaques were relatively rare. We observed PrPSc plaque-like structures in the periphery of the non-compact parts of Aβ plaques, as well as in tau protein-positive dystrophic structures. The AD ABC score according to the NIA-Alzheimer's association guidelines, and prion protein subtype with codon 129 methionine-valine (M/V) polymorphisms in sCJD, while representing key characteristics of these diseases, did not correlate with the morphology of the Aβ/PrPSc co-aggregates. However, our data showed that PrPSc aggregation could dominate during co-aggregation with non-compact Aβ in the periphery of Aβ plaques.

Entities:  

Keywords:  Alzheimer’s disease; Aβ; Creutzfeldt–Jakob disease; colocalization; confocal microscopy; plaques; prion protein; tau protein

Mesh:

Substances:

Year:  2021        PMID: 33672582      PMCID: PMC7924045          DOI: 10.3390/ijms22042099

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  31 in total

1.  Prion protein expression in senile plaques in Alzheimer's disease.

Authors:  I Ferrer; R Blanco; M Carmona; B Puig; R Ribera; M J Rey; T Ribalta
Journal:  Acta Neuropathol       Date:  2001-01       Impact factor: 17.088

2.  The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

Authors:  Leigh D Plant; John P Boyle; Ian F Smith; Chris Peers; Hugh A Pearson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

3.  p53-Dependent transcriptional control of cellular prion by presenilins.

Authors:  Bruno Vincent; Claire Sunyach; Hans-Dieter Orzechowski; Peter St George-Hyslop; Frédéric Checler
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

Review 4.  Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.

Authors:  Jogender Singh; Jayant B Udgaonkar
Journal:  Biochemistry       Date:  2015-07-17       Impact factor: 3.162

Review 5.  The function of the cellular prion protein in health and disease.

Authors:  Joel C Watts; Matthew E C Bourkas; Hamza Arshad
Journal:  Acta Neuropathol       Date:  2017-11-18       Impact factor: 17.088

Review 6.  Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease.

Authors:  Erik C Gunther; Stephen M Strittmatter
Journal:  J Mol Med (Berl)       Date:  2009-12-04       Impact factor: 4.599

7.  Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.

Authors:  Brent Race; Katie Phillips; Allison Kraus; Bruce Chesebro
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

Review 8.  Cerebral Small Vessel Disease.

Authors:  Jakub Litak; Marek Mazurek; Bartłomiej Kulesza; Paweł Szmygin; Joanna Litak; Piotr Kamieniak; Cezary Grochowski
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

9.  Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.

Authors:  Edward T Parkin; Nicole T Watt; Ishrut Hussain; Elizabeth A Eckman; Christopher B Eckman; Jean C Manson; Herbert N Baybutt; Anthony J Turner; Nigel M Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-15       Impact factor: 11.205

10.  Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation.

Authors:  Juliette Ezpeleta; Vincent Baudouin; Zaira E Arellano-Anaya; François Boudet-Devaud; Mathéa Pietri; Anne Baudry; Anne-Marie Haeberlé; Yannick Bailly; Odile Kellermann; Jean-Marie Launay; Benoit Schneider
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

View more
  2 in total

1.  Extracellular Prion Protein Aggregates in Nine Gerstmann-Sträussler-Scheinker Syndrome Subjects with Mutation P102L: A Micromorphological Study and Comparison with Literature Data.

Authors:  Nikol Jankovska; Radoslav Matej; Tomas Olejar
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

2.  Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt-Jakob Disease: A Retrospective Study in 215 Autopsy Cases.

Authors:  Nikol Jankovska; Robert Rusina; Jiri Keller; Jaromir Kukal; Magdalena Bruzova; Eva Parobkova; Tomas Olejar; Radoslav Matej
Journal:  Biomedicines       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.